D-PENICILLAMINE-INDUCED MYASTHENIA-GRAVIS - DIAGNOSIS OBSCURED BY COEXISTING CHRONIC OBSTRUCTIVE PULMONARY-DISEASE

被引:10
|
作者
ADELMAN, HM
WINTERS, PR
MAHAN, CS
WALLACH, PM
机构
[1] UNIV S FLORIDA,COLL MED,DEPT NEUROL,TAMPA,FL 33612
[2] OREGON HLTH SCI UNIV,DEPT INTERNAL MED,PORTLAND,OR 97201
来源
关键词
LUNG DISEASES; OBSTRUCTIVE; MYASTHENIA GRAVIS; D-PENICILLAMINE; ADVERSE EFFECTS; RESPIRATORY INSUFFICIENCY;
D O I
10.1097/00000441-199504000-00001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
D-penicillamine, a drug used to treat rheumatoid arthritis, Wilson's disease, and cystinuria, can cause myasthenia gravis. Fortunately, the myasthenia typically resolves after discontinuation of the drug. The diagnosis may be missed if weakness is blamed on a patient's underlying disease(s), in particular, rheumatoid arthritis. Reported here are the cases of two patients with chronic obstructive lung disease who were taking D-penicillamine for rheumatoid arthritis, then experienced increasing respiratory failure. At first, their problem seemed to stem from chronic lung disease, but further evaluation revealed the cause of the hypoventilation to be D-penicillamine-induced myasthenia gravis.
引用
收藏
页码:191 / 193
页数:3
相关论文
共 50 条
  • [1] D-PENICILLAMINE-INDUCED MYASTHENIA-GRAVIS
    PFEIFER, B
    KEMPKES, K
    LUTH, G
    KRAMER, G
    AKTUELLE RHEUMATOLOGIE, 1984, 9 (03) : 96 - 97
  • [2] D-PENICILLAMINE-INDUCED MYASTHENIA-GRAVIS IN RHEUMATOID-ARTHRITIS
    GORDON, RA
    BURNSIDE, JW
    ANNALS OF INTERNAL MEDICINE, 1977, 87 (05) : 578 - 579
  • [3] D-PENICILLAMINE-INDUCED MYASTHENIA-GRAVIS IN RHEUMATOID-ARTHRITIS
    FROELICH, CJ
    HASHIMOTO, F
    SEARLES, RP
    BANKHURST, AD
    JOURNAL OF RHEUMATOLOGY, 1979, 6 (02) : 237 - 239
  • [4] D-PENICILLAMINE-INDUCED MYASTHENIA-GRAVIS IN PRIMARY BILIARY-CIRRHOSIS
    MARCUS, SN
    CHADWICK, D
    WALKER, RJ
    GASTROENTEROLOGY, 1984, 86 (01) : 166 - 168
  • [5] AUTOANTIBODIES IN D-PENICILLAMINE-INDUCED MYASTHENIA-GRAVIS - A COMPARISON WITH IDIOPATHIC MYASTHENIA AND RHEUMATOID-ARTHRITIS
    MOREL, E
    FEUILLETFIEUX, MN
    VERNETDERGARABEDIAN, B
    RAIMOND, F
    DANGLEJAN, J
    BATAILLE, R
    SANY, J
    BACH, JF
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1991, 58 (03): : 318 - 330
  • [6] D-PENICILLAMINE INDUCED MYASTHENIA-GRAVIS
    FREY, RA
    KELLER, F
    MICHEL, BA
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1994, 124 (20) : 852 - 856
  • [7] D-PENICILLAMINE-INDUCED MYASTHENIA IN CHRONIC POLYARTHRITIS
    SEITZ, D
    FISCHER, K
    HOPF, HC
    JANZEN, RWC
    MEYER, W
    KLINISCHE WOCHENSCHRIFT, 1977, 55 (08): : 406 - 406
  • [8] FINE ANTIGENIC SPECIFICITIES OF ANTIBODIES IN SERA FROM PATIENTS WITH D-PENICILLAMINE-INDUCED MYASTHENIA-GRAVIS
    TZARTOS, SJ
    MOREL, E
    EFTHIMIADIS, A
    BUSTARRET, AF
    DANGLEJAN, J
    DROSOS, AA
    MOUTSOPOULOS, HA
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1988, 74 (01): : 80 - 86
  • [9] D-PENICILLAMINE-INDUCED MYASTHENIA-GRAVIS - A STUDY OF IMMUNO-CLINICAL CORRELATIONS IN 23 CASES
    DANGLEJAN, J
    MOREL, E
    FEUILLETFIEUX, MN
    RAIMOND, F
    GARABEDIAN, BVD
    JACOB, L
    BACH, JF
    PRESSE MEDICALE, 1985, 14 (46): : 2336 - 2340
  • [10] D-penicillamine-induced myasthenia gravis in a case of eosinophilic fasciitis
    Kato, Y
    Naito, Y
    Narita, Y
    Kuzuhara, S
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1997, 146 (01) : 85 - 86